CN Patent
CN108883160B — 因子xa解毒剂的冻干制剂
Assigned to Portola Pharmaceuticals LLC · Expires 2022-06-28 · 4y expired
What this patent protects
本公开涉及制备因子Xa(fXa)解毒剂的冻干制剂的溶液和方法。适用于冻干的合适的水性制剂可以包括fXa解毒剂、增溶剂、以及稳定剂,其中所述制剂在冻干期间不塌陷。
USPTO Abstract
本公开涉及制备因子Xa(fXa)解毒剂的冻干制剂的溶液和方法。适用于冻干的合适的水性制剂可以包括fXa解毒剂、增溶剂、以及稳定剂,其中所述制剂在冻干期间不塌陷。
Drugs covered by this patent
- Bevyxxa (BETRIXABAN) · Portola Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.